Tilray Inc (NASDAQ:TLRY) Holdings Lifted by Barclays PLC

Barclays PLC boosted its holdings in Tilray Inc (NASDAQ:TLRY) by 600.4% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 204,144 shares of the company’s stock after buying an additional 174,997 shares during the quarter. Barclays PLC’s holdings in Tilray were worth $359,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of TLRY. Ferguson Wellman Capital Management Inc. acquired a new position in Tilray in the 3rd quarter worth approximately $26,000. International Assets Investment Management LLC raised its stake in shares of Tilray by 335.3% during the 3rd quarter. International Assets Investment Management LLC now owns 23,639 shares of the company’s stock worth $42,000 after purchasing an additional 18,208 shares in the last quarter. Vista Capital Partners Inc. bought a new stake in Tilray in the third quarter worth approximately $42,000. Capital Management Associates Inc acquired a new position in Tilray during the third quarter worth $45,000. Finally, Pallas Capital Advisors LLC lifted its holdings in Tilray by 58.1% in the 3rd quarter. Pallas Capital Advisors LLC now owns 31,646 shares of the company’s stock worth $52,000 after purchasing an additional 11,632 shares during the last quarter. 9.35% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Canaccord Genuity Group upped their price target on Tilray from $2.00 to $3.00 and gave the stock a “buy” rating in a report on Monday, January 13th. Roth Mkm lowered their price objective on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a research report on Friday, October 11th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, Tilray has a consensus rating of “Hold” and an average target price of $2.70.

Tilray Price Performance

NASDAQ:TLRY opened at $1.20 on Monday. Tilray Inc has a one year low of $1.14 and a one year high of $2.97. The company has a market cap of $1.08 billion, a P/E ratio of -4.00 and a beta of 2.08. The firm’s fifty day moving average price is $1.32 and its two-hundred day moving average price is $1.60. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.47 and a quick ratio of 1.57.

Tilray (NASDAQ:TLRY) last posted its quarterly earnings data on Friday, January 10th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.07). Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The firm had revenue of $210.90 million for the quarter, compared to the consensus estimate of $216.34 million. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. Equities analysts expect that Tilray Inc will post -0.14 earnings per share for the current year.

Insider Buying and Selling

In related news, CFO Carl A. Merton bought 26,000 shares of the business’s stock in a transaction on Friday, November 15th. The shares were purchased at an average price of $1.36 per share, for a total transaction of $35,360.00. Following the completion of the transaction, the chief financial officer now directly owns 26,000 shares of the company’s stock, valued at approximately $35,360. This represents a ? increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. 0.87% of the stock is currently owned by company insiders.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.